← Analysis page  ·  Jay Singh hub  ·  Research hub

Actionable insights — Weekly SSR: a stress composite that predicts political intervention, short interest as squeeze fuel, sell-the-news discipline into capex prints, separating operating earnings from markups, the direct-selling-discount screen, and buying yield after the raise

The repeatable analysis behind the calls: not what he bought, but how he got there — an ex-Goldman special-situations process written so it can be rerun on the next geopolitical shock with an election clock attached, the next crowded short book, the next mega-cap that reports a record profit it didn't earn in cash, the next cheap compounder nobody is watching, the next deal trading below its take-out price, and the next income name that raises its dividend.
2026-JUL-26 · Weekly SSR research call (premium) · Jay Singh (Special Situations Report; ex-Goldman Sachs) · ▶ Transcript (PDF) · full analysis · report · weekly deck · notes
How to read this page: each insight is a method — the trigger that put him onto an idea, the steps that turned it into a position, and the signal to watch when re-running it. The boxed line shows how it played out in this call. (Premium recording with no public video, so no per-step video deep-links — the section time is shown as plain text and the full cues live in the saved notes.)

1. Build a multi-factor stress composite to predict the political response, then trade the window — 03:43

The repeatable method
  1. When a policy-maker has a visible incentive to intervene (an election, an inflation mandate, a poll number), stop forecasting the conflict and start forecasting the intervention. Ask which variables the decision-maker actually watches.
  2. Build a small composite from those variables — not a model, a dashboard of four things — and z-score each against its own history. Backtest the combined standard-deviation move at which intervention has historically arrived.
  3. When the composite reaches that threshold, you have a dated window, not a direction. Position for the de-escalation trade (short-covering assets: high-beta equity, small caps, duration) and against the escalation trade (crude), and size for the window, not forever.
  4. Cross-check the political clock separately: the closer a term-defining election, the stronger the incentive, and the more asymmetric the payoff.
Here: Signum Global Advisors' "Taco Index" (Andrew Bishop) = Brent crude + the US 10-yr yield + Strait-of-Hormuz vessel transits + the S&P level. Backtesting says a combined 2.3-3.4σ move (avg 2.9σ) has consistently forced presidential action to push energy prices and yields down. It flagged a window of "as early as July 26, no later than July 30" — de-escalation arrived July 27: crude −5%, 10-yr −5 bps, Nasdaq +1.36%, Russell +1.2%. The political clock behind it: the Nov 3 midterms and a stated desire to force oil back toward the $70 baseline from a >$100 spike, with a 75% probability of an effective ceasefire by Aug 31.
Watch for

2. Treat extreme short interest + a positioning washout as fuel, and wait for the spark — 03:43 / 28:23

The repeatable method
  1. Separate the two halves of a countertrend setup: fuel (how crowded and one-sided the positioning is) and the spark (a headline the crowd can't fade). Fuel alone goes nowhere; a spark into an un-crowded market fizzles.
  2. Measure the fuel with hard positioning data, not sentiment surveys: index short interest as a share of free float versus its own multi-decade history, and prime-brokerage flow (how much gross exposure hedge funds have cut, and what share of a prior accumulation they've reversed).
  3. Look for the turn in the flow data — the first week the same funds start re-buying after a large de-grossing — as confirmation the forced selling is finished.
  4. Then buy the sector that was de-grossed hardest, not the broad index; the squeeze concentrates where the covering has to happen.
Here: the fuel — S&P 500 short interest at 3.7% of free float, one of the highest since 2010, with hedge funds having cut momentum/semi longs by ~5% of gross market value (one of the largest reductions on record, per UBS) and reversed 80% of all net buying since mid-June. The turn — they started buying again last week; global semi net allocation went 10% → 24% (June record) → 19%, a "healthy correction," US semis 7% → 14% → 11%. The spark — the Iran halt plus Nvidia's $250B OpenAI guarantee. The expression: semis, not the index.
Watch for

3. Sell-the-news discipline: when a peer is punished for a disclosure you know is coming, wait for the print — 05:24 / 53:06

The repeatable method
  1. When the first company in a cohort reports and gets hit for a specific line item, identify whether that line item is structural to the cohort (everyone must disclose the same thing) or company-specific.
  2. If it's structural, assume every peer prints the same problem within days. Do not pre-position long into it, however cheap the peer looks — the information is already known and the reaction is the trade.
  3. Wait for the sell-the-news drop, then buy the layer of the value chain that benefits from the same disclosure (see insight 4). The bad news for the spender is confirmation for the supplier.
  4. Keep the two decisions separate: "is this a good business" and "is this week a good entry" are different questions, and only the second one is being answered.
Here: GOOGL reported first, raised capex to $195-205B, printed its first negative FCF quarter since the IPO and fell 6%. The instruction for the biggest earnings week of the quarter: "wait for sell-the-news first from Amazon, Microsoft this week, like Google" (AMZN, MSFT, META) — "their capex will likely have gone up like Google and that could be a sell-the-news event." The corollary he states outright: "when the market realizes all the Max7 guys are raising capex spending, you'll see another bid for the semiconductor names."
Watch for

4. Split reported earnings into operating profit vs mark-to-market gains — then go straight to the cash-flow statement and the commitments footnote — 05:24 / 41:42

The repeatable method
  1. On any record-earnings headline, immediately ask what share came from revaluing assets (equity stakes, investments) rather than selling products. Recompute the growth rate excluding those markups — that's the number the business actually earned.
  2. Check whether the marked-up asset can even be monetized (lock-ups, sale restrictions). A gain you can't sell into is an accounting entry, not capital.
  3. Go to free cash flow (operating cash flow minus capex), not EPS. Accounting spreads capex over years; cash doesn't. A company can post record EPS while burning cash.
  4. Read the purchase-commitments footnote — contracted future obligations for chips, power, buildings. That's the forward capex the guidance hasn't shown you yet, and its rate of change is the real signal.
  5. Translate the finding into a structural claim: sustained heavy capex to defend growth means lower margins and lower return on invested capital — a multiple story, not an earnings story.
Here: Alphabet's record $112B net income was 87% markups on SpaceX and Anthropic (with $80B of the $94B SpaceX stake sale-restricted); ex-markups, income grew ~2% sequentially. FCF was −$5.9B, the first negative quarter in 20+ years as a public company; capex guidance rose to $195-205B; and purchase commitments hit $811B, up $500B in three months ($201B short-term). Cohort-wide: consensus has hyperscaler FCF going negative in 2027 against >$1T of 2028 capex — which is exactly why the Max7 multiple compressed from 32× to 22× while earnings "soared."
Watch for

5. Test revenue quality by talking to the customer who pays the bill — 19:12

The repeatable method
  1. When a segment's revenue grows while its underlying volume shrinks, the growth is coming from price or from extraction. Find a large customer and ask what changed in how they are billed.
  2. Catalogue the specific mechanism changes — pricing model, targeting precision, spend caps, refund policy. Mechanism changes are verifiable facts; "monetization improvements" in a press release are not.
  3. Ask whether the customer has an alternative. Extraction without substitutes produces good numbers now and a fragile franchise later — so treat it as borrowed revenue and de-rate the terminal value, not the next quarter.
  4. Pair the finding with the volume data (is the underlying usage being cannibalized?) to decide whether this is a cycle or a decay.
Here: a Google advertiser spending ~$500k/yr documented four mechanism changes behind "healthy" search growth — the second-price auction was silently deprecated (you used to pay a penny above the second-highest bid; now you pay your full bid/budget cap), exact-match targeting diluted into unlimited "close variants" that can't be disabled, daily budget caps exceeded by 2×, and no refunds or recourse — all while search volume is cannibalized by non-monetized LLM queries. Verdict: "these are the actions of a company whose core business is in decline but desperately needs to pump quarterly earnings… at the altar of AI capex, Google is sacrificing its golden goose of search."
Watch for

6. The "surging earnings, shrinking multiple" special-situation screen — and name the discount you're being paid to accept — 23:38

The repeatable method
  1. Screen for the scissors: forward EBITDA estimates rising over the last twelve months while EV/EBITDA falls over the same period. Rising estimates plus a falling multiple is a market refusing to believe the numbers — that's the whole opportunity.
  2. Verify the earnings are cash: measure EBITDA-to-free-cash-flow conversion and the free-cash-flow yield on the equity. A high conversion rate turns a cheap multiple into a real return.
  3. Use the dividend record as the durability test — consecutive quarters paid without a cut, and whether the payout is covered by that cash conversion, not by borrowing. Check leverage post-deal is falling back toward the pre-deal level.
  4. Then write down explicitly why it's cheap and decide if each reason is permanent or temporary: a category discount (the multiple the market applies to all peers), a jurisdiction/currency discount, and a transaction-digestion discount all decay at different speeds. Only the temporary ones pay you.
  5. For the acquisition specifically, get the first consolidated month's contribution and management's pro-forma trailing-twelve-month EPS uplift — that's the cleanest early evidence of accretion.
Here: BWMX — NTM EBITDA estimates +50% in a year while EV/EBITDA fell 30%, to 3.8× 2027E; EBITDA doubling ~2.0B → ~4.3B pesos (2024 → 2027E); >80% EBITDA-to-FCF conversion (~3B pesos of FCF on an ~11B cap); an 8.6% dividend, 26 consecutive quarters; leverage back to 1.6× from a brief post-deal 2.6×; guidance raised from 4.8% to 18-22% growth. Tupperware LatAm delivered 11% of revenue / 16% of EBITDA in its first consolidated month → pro-forma TTM EPS +36%. The three named discounts: the direct-selling discount (Wall Street's habitual 3-6× on DTC networks over distributor-churn fear), EM/FX, and M&A digestion — all three temporary.
Watch for

7. Merger-arb: convert the deal into a buy limit, and price the antitrust risk separately — 34:09 / 55:52

The repeatable method
  1. Start from the announced consideration and the expected close date, then work backwards to the price that pays you an acceptable annualised return for the deal risk. That price — not the current quote — is your standing limit order.
  2. Score the antitrust/regulatory risk on its own: overlapping share in a defined market, the regulator's recent behaviour, whether the acquirer is foreign or domestic. Low-overlap consumer deals are the cheap end of the risk curve.
  3. Let volatility come to you. A post-announcement drift below the limit is the entry; chasing near the deal price surrenders the whole spread.
  4. On a name already owned, treat a widening spread as an invitation to add rather than a warning — as long as your regulatory score hasn't changed.
Here: UTZ soared ~90% on Intersnack's $14.25/share cash take-private (Q4 close) from a ~$7.25 close. The rule stated as a number: "anything below 13 here is kind of buyable" — ~10% to terms in a few months — with the risk scored explicitly: "there's not a lot of antitrust risk here." On the widening side: WBD at a 15% spread — "especially with the news this week, we'll be adding to it."
Watch for

8. Hunt where nobody is looking — the cheap-quality contrarian screen — 41:42 / 01:03:30

The repeatable method
  1. When attention (and money) concentrates in one theme, invert the screen: within the unfashionable part of a sector, rank names by valuation and by quality of the underlying business.
  2. Prefer the ones with no story at all. A cheap, well-run business with no narrative needs only an in-line quarter to re-rate, because expectations have been abandoned — "the lack of an issue is a positive in itself."
  3. Set the bar at "beat and raise," not "beat": the raise is what forces analysts to move estimates, which is what moves the multiple.
  4. Apply the same test to what you refuse to buy: a beaten-down name whose end-market budget is being structurally redirected elsewhere is cheap for a reason — wait for the deceleration to finish rather than catching it.
Here: ROP+10%, the most since 2020, on adjusted EPS $5.38 vs $5.29, revenue $2.11B vs $2.10B and FY guidance raised to $22.15-22.30. The lesson stated directly: "Roper was one of the cheaper industrial software companies, and then they crushed — they're up 10%, but nobody was looking at that name. Being contrarian in this type of market is definitely a really important thing." The mirror image is IBM: also beaten down, but its budget is being redirected to core AI infrastructure, so "next quarter could miss as well… wait another quarter or two… I just don't see a reason to really own it." Same screen, opposite answer.
Watch for

9. In income names, buy after the dividend is raised — the raise is the signal, not the yield — 56:37 / 58:49

The repeatable method
  1. For rate-sensitive income vehicles (mortgage REITs, BDCs), treat the headline yield as unreliable — it's highest exactly when the market expects a cut. Look at the dividend history instead.
  2. A raise after several years of flat payments is management telling you the spread they earn has stabilised. That is a far better entry signal than the yield, because it is the one number they can't fudge and won't reverse casually.
  3. State the macro condition the whole basket depends on and check it separately (here: has the long yield peaked?). If the condition holds, everything in the basket works — so size the basket, and use the capital-structure ladder to set risk: the baby bond/preferred for income safety, the common for upside.
  4. Enter the commons on a price rule (a level, not a feeling), scaling in as they fall rather than sizing all at once.
Here: NLY raised its quarterly dividend to $0.75 after ~six quarters at $0.70 and ~eight at $0.65 → a 13.4% yield — "quite positive… Annaly after the dividend raise is also an add." The basket around it: the RWTS baby bond at ~10% (the most recent add, safest rung), DX ("a very, very high yield"), RWT common below $5 ("a great add from a three handle" — a scaled entry), and AGNC. The condition, stated plainly: "if you believe rates have peaked, all of them are pretty much adds here" — with the 10-yr at 4.63% and "might have peaked at 4.7 if this war is over."
Watch for

10. Decide which side of a capital flow you're on — and stress-test the bear case on the receiving side — 37:12 / 41:42

The repeatable method
  1. Map a boom as a transfer: who is spending the cash and who is receiving it. Then check the cash-flow statements on both sides — the spenders' FCF collapsing is the same event as the receivers' revenue rising.
  2. Default to the receiving side while the spenders are locked in by competitive necessity ("they cannot afford to lose the race"), because their capex is the receivers' revenue and it is contractually committed.
  3. Before sizing up, take the strongest bear case against the receivers seriously and work the physical mechanics, not the headline. Cheaper inputs usually mean more total consumption, not less.
  4. Confirm with pricing evidence from the receivers' own market — sold-out capacity, forecast price increases, the absence of a cheaper alternative supplier — and with behavioural tells (a powerful customer publicly flattering the supplier).
  5. Keep the financing risk, not the demand risk, as the thing you monitor: if the spenders must borrow to keep spending, widening credit spreads are what actually ends the flow.
Here: the transfer is explicit — "an epic wealth transfer from hyperscaler capex to the semiconductor companies receiving it"; hyperscalers are ~16% of the S&P, semis ~19%. The bear case tested: "is open-source AI bad for memory?" Bank of America's mechanics say the opposite — closed models share HBM pools, but 10,000 enterprises self-hosting an open model replicate the weights across 10,000 separate memory pools, and at 1M-token contexts the KV cache alone exceeds 40 GB per session. Confirmation: Morgan Stanley's 25% memory price increases, MU's HBM sold out through 2027, CXMT's $1,240 64GB DDR5 module proving "there is no cheap memory," a Micron/Meta paper showing a 38× slowdown when data spills out of DRAM, and Musk pausing a Tesla call to thank Micron for its pricing. The monitor: "what if the cost of this debt and equity goes up — spreads are widening."
Watch for

Methods distilled from the premium Special Situations Report weekly call (2026-07-26; transcript, report and strategy-deck PDFs in this folder; notes in transcript.md) for personal study. Not investment advice. © Special Situations Report for source material.